BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

439 related articles for article (PubMed ID: 19508946)

  • 1. Adverse effects of therapy for ANCA-associated vasculitis.
    Turnbull J; Harper L
    Best Pract Res Clin Rheumatol; 2009 Jun; 23(3):391-401. PubMed ID: 19508946
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Primary systemic vasculitis.
    Day C; Savage C
    Minerva Med; 2001 Oct; 92(5):349-63. PubMed ID: 11675579
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Treatment of patients with Wegener's granulomatosis or ANCA-associated vasculitis].
    Tervaert JW; Stegeman CA
    Ned Tijdschr Geneeskd; 2003 Nov; 147(46):2265-7. PubMed ID: 14655291
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ANCA-associated renal vasculitis at the end of the twentieth century--a disease of older patients.
    Harper L; Savage CO
    Rheumatology (Oxford); 2005 Apr; 44(4):495-501. PubMed ID: 15613403
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ANCA-associated renal vasculitis--epidemiology, diagnostics and treatment.
    Ríhová Z; Jancová E; Merta M; Tesar V
    Prague Med Rep; 2004; 105(3):237-60. PubMed ID: 15782551
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pulse versus daily oral cyclophosphamide for induction of remission in antineutrophil cytoplasmic antibody-associated vasculitis (CYCLOPS study)].
    Kötter I
    Z Rheumatol; 2009 Sep; 68(7):575-7. PubMed ID: 19652987
    [No Abstract]   [Full Text] [Related]  

  • 7. [ANCA-associated vasculitis (Wegener's granulomatosis, Churg-Strauss syndrome, microscopic polyangiitis). 3. Therapeutic procedure].
    Reinhold-Keller E; Tatsis E; Gross WL
    Z Rheumatol; 1995; 54(5):303-9. PubMed ID: 8578886
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma exchange in the treatment of Wegener's granulomatosis, microscopic polyangiitis, Churg-Strauss syndrome and renal limited vasculitis.
    Casian A; Jayne D
    Curr Opin Rheumatol; 2011 Jan; 23(1):12-7. PubMed ID: 21124082
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vasculitis in the seriously ill patient: diagnostic approaches and therapeutic options in ANCA-associated vasculitis.
    Schmitt WH; Gross WL
    Kidney Int Suppl; 1998 Feb; 64():S39-44. PubMed ID: 9475487
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Churg-Strauss angiitis.
    Sinico RA; Bottero P
    Best Pract Res Clin Rheumatol; 2009 Jun; 23(3):355-66. PubMed ID: 19508943
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical and pathological characteristics and outcomes of Chinese patients with primary anti-neutrophil cytoplasmic antibodies-associated systemic vasculitis with immune complex deposition in kidney.
    Yu F; Chen M; Wang SX; Zou WZ; Zhao MH; Wang HY
    Nephrology (Carlton); 2007 Feb; 12(1):74-80. PubMed ID: 17295665
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MPO-ANCA-associated pulmonary-renal vasculitis in a patient with diabetes mellitus.
    Keven K; Akar H; Kutlay S; Nergizoglu G; Erbay B; Erturk S
    J Nephrol; 2002; 15(6):720-3. PubMed ID: 12495292
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcome of thirty patients with ANCA-associated renal vasculitis admitted to the intensive care unit.
    Frausova D; Brejnikova M; Hruskova Z; Rihova Z; Tesar V
    Ren Fail; 2008; 30(9):890-5. PubMed ID: 18925529
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rituximab as rescue therapy in anti-neutrophil cytoplasmic antibody-associated vasculitis: a single-centre experience with 15 patients.
    Lovric S; Erdbruegger U; Kümpers P; Woywodt A; Koenecke C; Wedemeyer H; Haller H; Haubitz M
    Nephrol Dial Transplant; 2009 Jan; 24(1):179-85. PubMed ID: 18685144
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of ANCA-associated systemic vasculitis.
    Belmont HM
    Bull NYU Hosp Jt Dis; 2006; 64(1-2):60-6. PubMed ID: 17121492
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence-based management of ANCA vasculitis.
    Carruthers D; Sherlock J
    Best Pract Res Clin Rheumatol; 2009 Jun; 23(3):367-78. PubMed ID: 19508944
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term treatment results and the immunoglobulin G subclass distribution patterns of proteinase-3-antineutrophil cytoplasm antibody (ANCA) and myeloperoxidase-ANCA in ANCA-associated vasculitis.
    Almroth G; Berlin G; Andersson B; Hahn-Zoric M
    Scand J Urol Nephrol; 2009; 43(2):160-70. PubMed ID: 18979374
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vasculitis of the upper and lower airway.
    Martinez Del Pero M; Sivasothy P
    Best Pract Res Clin Rheumatol; 2009 Jun; 23(3):403-17. PubMed ID: 19508947
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating endothelial cells in relapse and limited granulomatous disease due to ANCA associated vasculitis.
    Woywodt A; Goldberg C; Kirsch T; de Groot K; Erdbruegger U; Haller H; Haubitz M
    Ann Rheum Dis; 2006 Feb; 65(2):164-8. PubMed ID: 16150786
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antineutrophil cytoplasmic autoantibody-associated small-vessel vasculitis.
    Kallenberg CG
    Curr Opin Rheumatol; 2007 Jan; 19(1):17-24. PubMed ID: 17143091
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.